TY - JOUR
T1 - The Diagnosis and Management of Bipolar I and II Disorders
T2 - Clinical Practice Update
AU - Bobo, William V.
N1 - Funding Information:
Grant Support: Dr Bobo's work has been supported by the Mayo Foundation for Medical Education and Research.
Publisher Copyright:
© 2017 Mayo Foundation for Medical Education and Research
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2017/10
Y1 - 2017/10
N2 - Bipolar disorders, including bipolar I disorder (BP-I) and bipolar II disorder (BP-II), are common, potentially disabling, and, in some cases, life-threatening conditions. Bipolar disorders are characterized by alternating episodes of mania or hypomania and depression, or mixtures of manic and depressive features. Bipolar disorders present many diagnostic and therapeutic challenges for busy clinicians. Adequate management of bipolar disorders requires pharmacotherapy and psychosocial interventions targeted to the specific phases of illness. Effective treatments are available for each illness phase, but mood episode relapses and incomplete responses to treatment are common, especially for the depressive phase. Mood symptoms, psychosocial functioning, and suicide risk must, therefore, be continually reevaluated, and, when necessary, the plan of care must be adjusted during long-term treatment. Many patients will require additional treatment of comorbid psychiatric and substance use disorders and management of a variety of commonly co-occurring chronic general medical conditions.
AB - Bipolar disorders, including bipolar I disorder (BP-I) and bipolar II disorder (BP-II), are common, potentially disabling, and, in some cases, life-threatening conditions. Bipolar disorders are characterized by alternating episodes of mania or hypomania and depression, or mixtures of manic and depressive features. Bipolar disorders present many diagnostic and therapeutic challenges for busy clinicians. Adequate management of bipolar disorders requires pharmacotherapy and psychosocial interventions targeted to the specific phases of illness. Effective treatments are available for each illness phase, but mood episode relapses and incomplete responses to treatment are common, especially for the depressive phase. Mood symptoms, psychosocial functioning, and suicide risk must, therefore, be continually reevaluated, and, when necessary, the plan of care must be adjusted during long-term treatment. Many patients will require additional treatment of comorbid psychiatric and substance use disorders and management of a variety of commonly co-occurring chronic general medical conditions.
UR - http://www.scopus.com/inward/record.url?scp=85028871344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028871344&partnerID=8YFLogxK
U2 - 10.1016/j.mayocp.2017.06.022
DO - 10.1016/j.mayocp.2017.06.022
M3 - Review article
C2 - 28888714
AN - SCOPUS:85028871344
SN - 0025-6196
VL - 92
SP - 1532
EP - 1551
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 10
ER -